Company Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-02-26 pm EST 5-day change 1st Jan Change
190,100 KRW +4.74% Intraday chart for Celltrion, Inc. +4.22% -5.66%

Business Summary

Celltrion, Inc. is a Korea-based company mainly engaged in the production and sale of biopharmaceuticals. Along with subsidiaries, the Company operates its business through three segments. The Biopharmaceutical segment is involved in the manufacturing and sale of biopharmaceutical products such as multivitamins, blood circulation remedies, blood cancer treatments and breast cancer treatments. The Chemical Pharmaceutical segment is involved in the manufacturing and sale of therapeutic drugs for liver disease under the name of Godex, as well as the treatment of autoimmune diseases under the name of Remsima. The Other segment manufactures and sells other generic drugs. The Company distributes its products within the domestic market and to overseas markets.

Number of employees: 2,034

Sales per Business

KRW in Million2021Weight2022Weight Delta
Biopharmaceutical
84.8 %
1,615,840 84.5 % 1,937,469 84.8 % +19.90%
Chemical Drugs
28.6 %
556,711 29.1 % 653,519 28.6 % +17.39%
Reconciling Items
-13.6 %
-264,004 -13.8 % -310,898 -13.6 % +17.76%
Others
0.2 %
3,054 0.2 % 3,877 0.2 % +26.93%

Sales per region

KRW in Million2021Weight2022Weight Delta
South Korea
91.5 %
1,779,873 93.1 % 2,090,465 91.5 % +17.45%
United States
5.8 %
84,609 4.4 % 131,433 5.8 % +55.34%
Asia
2.7 %
47,119 2.5 % 62,069 2.7 % +31.73%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 07-04-23
Director of Finance/CFO 49 -
Chairman 66 -
Compliance Officer 42 -
Corporate Officer/Principal 54 -
Corporate Officer/Principal 57 -
Corporate Officer/Principal 60 -
Corporate Officer/Principal 57 -

Members of the board

Members of the board TitleAgeSince
Chairman 66 -
Director/Board Member 71 14-12-07
Director/Board Member 66 -
Director/Board Member 65 08-07-16
Director/Board Member 64 09-03-19
Chief Executive Officer 62 07-04-23
Director/Board Member 66 14-03-26
Director/Board Member 64 -
Director/Board Member 61 -
Director/Board Member 48 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 218,049,762 79,644,372 ( 36.53 %) 5,165,802 ( 2.369 %) 36.53 %

Shareholders

NameEquities%Valuation
51,683,588 23.71 % 6 959 M ₩
National Pension Service of Korea
5.277 %
11,502,033 5.277 % 1 549 M ₩
Temasek Holdings Pte Ltd. (Investment Management)
2.534 %
5,523,531 2.534 % 744 M ₩
4,508,124 2.068 % 607 M ₩
Celltrion Inc. Employee Stock Ownership ASSN.
0.2462 %
536,669 0.2462 % 72 M ₩
State Street Global Advisors Ltd.
0.1253 %
273,131 0.1253 % 37 M ₩
250,384 0.1149 % 34 M ₩
Sjunde AP-fonden
0.1005 %
219,102 0.1005 % 30 M ₩
205,618 0.0943 % 28 M ₩
Northern Trust Fund Managers (Ireland) Ltd.
0.0688 %
149,867 0.0688 % 20 M ₩

Holdings

NameEquities%Valuation
21,712,012 52.20% 1,660,957,194 $
4,508,124 2.07% 606,983,012 $
1,631,134 10.22% 7,149,538 $

Company contact information

Celltrion, Inc.

23 Academy-ro Yeonsu-gu

22014, Inchon

+

http://www.celltrion.com
address Celltrion, Inc.(A068270)
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW